More than 41,000 COVID-19 patients hospitalized across the country, a 40 percent rise in the past month
The 2020 Flu Season’s Delayed Start is Good News
The US Centers for Disease Control and Prevention (CDC) reported 1.2% of patient visits reported through the U.S. Outpatient Influenza-like Illness Surveillance Network were due to influenza-like illness (ILI) during week #42.
This ILI percentage is well below the national baseline rate of 2.6%.
‘While outpatient ILI activity remains low, many people are accessing the healthcare system in alternative settings. Therefore, traditional healthcare providers are not seeing increased numbers of cases of ILI,’ says the CDC.
Survival From COVID-19 High in Patients With Psoriasis
Risk for hospitalization increased for patients using nonbiologic systemic therapy versus biologics
Convalescent Plasma Has Limited Benefit for Moderate COVID-19
Randomized phase II trial shows no drop in progression to severe disease, all-cause deaths
CDC Plans Cellphone COVID-19 Vaccine Tracking System
Health checks will be done by text messages and email every day during the first week after vaccination
FDA Needs More Safety Data on COVID-19 Vaccines, Experts Say
Polls show Americans getting more skeptical about a vaccine, worry that approval process is being rushed
U.S. CDC Discourages Cruise Ship Voyages
The US Centers for Disease Control and Prevention (CDC) typically posts travel health notices for countries and other international destinations, not transportation, such as cruise ships.
However, because of the unprecedented nature of the novel SARS-CoV-2 coronavirus pandemic, and the increased risk of virus transmission on cruise ships, the U.S. government is advising U.S. travelers to defer all cruise travel.
Tocilizumab Does Not Prevent Intubation, Death in COVID-19
Intubation or death, disease worsening similar for tocilizumab, placebo in hospitalized patients
CDC: Number of COVID-19 Deaths May Be Underreported
Only two-thirds of the nearly 300,000 excess deaths in 2020 are attributed to COVID-19
U.S. COVID-19 Vaccine Trial Enrolls 30,000
Moderna says it is on track to apply for FDA approval to market the vaccine in early December